Literature DB >> 27212660

Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling.

Alesha Grant1, Sanket S Ponia2, Shashank Tripathi1, Vinod Balasubramaniam1, Lisa Miorin1, Marion Sourisseau3, Megan C Schwarz3, Mari Paz Sánchez-Seco4, Matthew J Evans3, Sonja M Best2, Adolfo García-Sastre5.   

Abstract

The ongoing epidemic of Zika virus (ZIKV) illustrates the importance of flaviviruses as emerging human pathogens. All vector-borne flaviviruses studied thus far have to overcome type I interferon (IFN) to replicate and cause disease in vertebrates. The mechanism(s) by which ZIKV antagonizes IFN signaling is unknown. Here, we report that the nonstructural protein NS5 of ZIKV and other flaviviruses examined could suppress IFN signaling, but through different mechanisms. ZIKV NS5 expression resulted in proteasomal degradation of the IFN-regulated transcriptional activator STAT2 from humans, but not mice, which may explain the requirement for IFN deficiency to observe ZIKV-induced disease in mice. The mechanism of ZIKV NS5 resembles dengue virus (DENV) NS5 and not its closer relative, Spondweni virus (SPOV). However, unlike DENV, ZIKV did not require the E3 ubiquitin ligase UBR4 to induce STAT2 degradation. Hence, flavivirus NS5 proteins exhibit a remarkable functional convergence in IFN antagonism, albeit by virus-specific mechanisms.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27212660      PMCID: PMC4900918          DOI: 10.1016/j.chom.2016.05.009

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  44 in total

1.  IL-28, IL-29 and their class II cytokine receptor IL-28R.

Authors:  Paul Sheppard; Wayne Kindsvogel; Wenfeng Xu; Katherine Henderson; Stacy Schlutsmeyer; Theodore E Whitmore; Rolf Kuestner; Ursula Garrigues; Carl Birks; Jenny Roraback; Craig Ostrander; Dennis Dong; Jinu Shin; Scott Presnell; Brian Fox; Betty Haldeman; Emily Cooper; David Taft; Teresa Gilbert; Francis J Grant; Monica Tackett; William Krivan; Gary McKnight; Chris Clegg; Don Foster; Kevin M Klucher
Journal:  Nat Immunol       Date:  2002-12-02       Impact factor: 25.606

2.  Zika virus. I. Isolations and serological specificity.

Authors:  G W A DICK; S F KITCHEN; A J HADDOW
Journal:  Trans R Soc Trop Med Hyg       Date:  1952-09       Impact factor: 2.184

3.  Zika virus. II. Pathogenicity and physical properties.

Authors:  G W A DICK
Journal:  Trans R Soc Trop Med Hyg       Date:  1952-09       Impact factor: 2.184

4.  Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins.

Authors:  Wen Jun Liu; Xiang Ju Wang; Vladislav V Mokhonov; Pei-Yong Shi; Richard Randall; Alexander A Khromykh
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize N-degrons.

Authors:  Takafumi Tasaki; Lubbertus C F Mulder; Akihiro Iwamatsu; Min Jae Lee; Ilia V Davydov; Alexander Varshavsky; Mark Muesing; Yong Tae Kwon
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

6.  Spondweni virus infection in a foreign resident of Upper Volta.

Authors:  M S Wolfe; C H Calisher; K McGuire
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

7.  Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression.

Authors:  Kirk J Lubick; Shelly J Robertson; Kristin L McNally; Brett A Freedman; Angela L Rasmussen; R Travis Taylor; Avram D Walts; Seitaro Tsuruda; Mizuki Sakai; Mariko Ishizuka; Elena F Boer; Erin C Foster; Abhilash I Chiramel; Conrad B Addison; Richard Green; Daniel L Kastner; Michael G Katze; Steven M Holland; Antonella Forlino; Alexandra F Freeman; Manfred Boehm; Kentaro Yoshii; Sonja M Best
Journal:  Cell Host Microbe       Date:  2015-07-08       Impact factor: 21.023

8.  Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study.

Authors:  Van-Mai Cao-Lormeau; Alexandre Blake; Sandrine Mons; Stéphane Lastère; Claudine Roche; Jessica Vanhomwegen; Timothée Dub; Laure Baudouin; Anita Teissier; Philippe Larre; Anne-Laure Vial; Christophe Decam; Valérie Choumet; Susan K Halstead; Hugh J Willison; Lucile Musset; Jean-Claude Manuguerra; Philippe Despres; Emmanuel Fournier; Henri-Pierre Mallet; Didier Musso; Arnaud Fontanet; Jean Neil; Frédéric Ghawché
Journal:  Lancet       Date:  2016-03-02       Impact factor: 79.321

9.  Unanchored K48-linked polyubiquitin synthesized by the E3-ubiquitin ligase TRIM6 stimulates the interferon-IKKε kinase-mediated antiviral response.

Authors:  Ricardo Rajsbaum; Gijs A Versteeg; Sonja Schmid; Ana M Maestre; Alan Belicha-Villanueva; Carles Martínez-Romero; Jenish R Patel; Juliet Morrison; Giuseppe Pisanelli; Lisa Miorin; Maudry Laurent-Rolle; Hong M Moulton; David A Stein; Ana Fernandez-Sesma; Benjamin R tenOever; Adolfo García-Sastre
Journal:  Immunity       Date:  2014-05-29       Impact factor: 31.745

10.  Characterization of a Novel Murine Model to Study Zika Virus.

Authors:  Shannan L Rossi; Robert B Tesh; Sasha R Azar; Antonio E Muruato; Kathryn A Hanley; Albert J Auguste; Rose M Langsjoen; Slobodan Paessler; Nikos Vasilakis; Scott C Weaver
Journal:  Am J Trop Med Hyg       Date:  2016-03-28       Impact factor: 2.345

View more
  373 in total

1.  Persistent Zika Virus Clinical Susceptibility despite Reduced Viral Burden in Mice with Expanded Virus-Specific CD8+ T Cells Primed by Recombinant Listeria monocytogenes.

Authors:  Ashley R Burg; John J Erickson; Lucien H Turner; Giang Pham; Jeremy M Kinder; Sing Sing Way
Journal:  J Immunol       Date:  2020-06-10       Impact factor: 5.422

2.  Quantitative Proteomic Analysis of Mosquito C6/36 Cells Reveals Host Proteins Involved in Zika Virus Infection.

Authors:  Qi-Lin Xin; Cheng-Lin Deng; Xi Chen; Jun Wang; Shao-Bo Wang; Wei Wang; Fei Deng; Bo Zhang; Gengfu Xiao; Lei-Ke Zhang
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

Review 3.  Maternal-Fetal Transmission of Zika Virus: Routes and Signals for Infection.

Authors:  Bin Cao; Michael S Diamond; Indira U Mysorekar
Journal:  J Interferon Cytokine Res       Date:  2017-04-12       Impact factor: 2.607

Review 4.  Animal Models of Zika Virus Infection, Pathogenesis, and Immunity.

Authors:  Thomas E Morrison; Michael S Diamond
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

5.  Zika Virus Causes Acute and Chronic Prostatitis in Mice and Macaques.

Authors:  Jacques Halabi; Brett W Jagger; Vanessa Salazar; Emma S Winkler; James P White; Peter A Humphrey; Alec J Hirsch; Daniel N Streblow; Michael S Diamond; Kelle Moley
Journal:  J Infect Dis       Date:  2020-04-07       Impact factor: 5.226

6.  Molecular cloning and characterization of the genes encoding the proteins of Zika virus.

Authors:  Wangheng Hou; Ruth Cruz-Cosme; Najealicka Armstrong; Lilian Akello Obwolo; Fayuan Wen; Wenhui Hu; Min-Hua Luo; Qiyi Tang
Journal:  Gene       Date:  2017-07-15       Impact factor: 3.688

7.  Global Interactomics Uncovers Extensive Organellar Targeting by Zika Virus.

Authors:  Etienne Coyaud; Charlene Ranadheera; Derrick Cheng; João Gonçalves; Boris J A Dyakov; Estelle M N Laurent; Jonathan St-Germain; Laurence Pelletier; Anne-Claude Gingras; John H Brumell; Peter K Kim; David Safronetz; Brian Raught
Journal:  Mol Cell Proteomics       Date:  2018-07-23       Impact factor: 5.911

Review 8.  Taking the defensive: Immune control of Zika virus infection.

Authors:  James R Bowen; Matthew G Zimmerman; Mehul S Suthar
Journal:  Virus Res       Date:  2017-09-01       Impact factor: 3.303

Review 9.  Zika Virus: Immunity and Vaccine Development.

Authors:  Theodore C Pierson; Barney S Graham
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

Review 10.  Protective and Pathogenic Effects of Interferon Signaling During Pregnancy.

Authors:  Rebecca L Casazza; Helen M Lazear; Jonathan J Miner
Journal:  Viral Immunol       Date:  2019-09-23       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.